19542-51-9

Basic information

• Product Name: Z-VAL-PHE-OH
• Synonyms: Z-L-VALYL-L-PHENYLALANINE;Z-VAL-PHE-OH;N-CBZ-VAL-PHE;N-BENZYLOXYCARBONYL-L-VALYL-L-PHENYLALANINE;z-val-phe;N-benzyloxycarbonyl-valyl-phenylalanine methyl ester;N-carbobenzyloxy-Val-Phe;Z-Val-Phe-OH≥ 99% (HPLC)
• CAS NO: 19542-51-9
• Molecular Formula: C₂₂H₂₆N₂O₅
• Molecular Weight: 398.45
• Product Categories: Amino Acid Derivatives;Dipeptides;Dipeptides and Tripeptides;Peptides
• Mol File: 19542-51-9.mol
• Article Data: 12

Chemical Properties

• Melting Point: 150 °C
• Boiling Point: 648.6 °C at 760 mmHg
• Flash Point: 346.1 °C
• Appearance: /
• Density: 1.211 g/cm³
• Vapor Pressure: 1.04E-17mmHg at 25°C
• Refractive Index: 1.569
• Storage Temp.: −20°C
• PKA: 3.53±0.10(Predicted)
• CAS DataBase Reference: Z-VAL-PHE-OH(CAS DataBase Reference)
• NIST Chemistry Reference: Z-VAL-PHE-OH(19542-51-9)
• EPA Substance Registry System: Z-VAL-PHE-OH(19542-51-9)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 19542-51-9(Hazardous Substances Data)

Usage

Chemical Properties

White powder

InChI:InChI=1/C22H26N2O5/c1-15(2)19(24-22(28)29-14-17-11-7-4-8-12-17)20(25)23-18(21(26)27)13-16-9-5-3-6-10-16/h3-12,15,18-19H,13-14H2,1-2H3,(H,23,25)(H,24,28)(H,26,27)/t18-,19-/m0/s1

Upstream product

• 63-91-2 L-phenylalanine 
• 1149-26-4 (S)-N-(benzyloxycarbonyl)valine 
• 33857-66-8 N-benzyloxycarbonyl-L-valine 2-pyridylthiol ester 
• 820239-44-9 benzyl (S)-(1-(1H-benzo[d][1,2,3]triazol-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate 
• 4817-95-2 N-(benzyloxycarbonyl)-L-valyl-L-phenylalanine methyl ester 
• 7524-50-7 methyl (2S)-2-amino-3-phenylpropanoate hydrochloride 
• 25529-25-3 N-benzyloxycarbonyl-L-valine pentafluorophenyl ester 
• 88224-20-8 N-Benzyloxycarbonyl-L-valyl-L-phenylalanin-allylester 
• 3496-11-5 2,5-dioxopyrrolidin-1-yl (2S)-2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate 

Downstream Products

• 74757-94-1 N-Z-valyl-L-phenylalanyl-L-glutamic acid γ-methylester 
• 180799-66-0 [(S)-1-((S)-4-Benzyl-5-oxo-oxazolidine-3-carbonyl)-2-methyl-propyl]-carbamic acid benzyl ester 
• 1355251-80-7 1,4:3,6-dianhydro-5-O-(benzyl)-2-N-(N-carbobenzyloxyvaline-phenylalanine)-D-glucitol 
• 145428-03-1 (N-Benzyloxycarbonyl-L-valyl-L-phenylalanyl)diazomethane 
• 151920-09-1 [(S)-1-((S)-1-Benzyl-2-morpholin-4-yl-2-oxo-ethylcarbamoyl)-2-methyl-propyl]-carbamic acid benzyl ester 
• 121253-52-9 N-<(phenylmethoxy)carbonyl>-L-valyl-N'-methoxy-N'-methyl-L-phenylalaninamide 
• 146766-10-1 (S)-2-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylamino)-3-phenyl-propionic acid 2,5-dioxo-pyrrolidin-1-yl ester 
• 548462-64-2 C₃₀H₄₂N₄O₅ 
• 1418732-83-8 C₃₀H₄₈N₄O₄ 
• 651321-80-1 C₃₀H₄₂N₄O₄ 
• 1418732-77-0 C₃₁H₅₀N₄O₄ 
• 548462-60-8 C₃₁H₄₄N₄O₄ 

Relevant articles and documents

A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors**

The COVID-19 pathogen, SARS-CoV-2, requires its main protease (SC2MPro) to digest two of its translated long polypeptides to form a number of mature proteins that are essential for viral replication and pathogenesis. Inhibition of this vital pr

Convenient green preparation of dipeptides using unprotected α-amino acids

Dipeptides and amides were obtained in high yields from N-carbobenzyloxy α-amino acids and 3-phenylpropanoic acid with unprotected α-amino acids via the corresponding mixed carbonic carboxylic anhydrides using ethyl chloroformate and triethylamine by an ecological and convenient method in which the protection of C-terminals is not needed.

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety

We describe here the design, synthesis and biological evaluation of a series of molecules toward the development of novel peptidomimetic inhibitors of SARS-CoV 3CLpro. A docking study involving binding between the initial lead compound 1 and th